Pirfenidone reduces subchondral bone loss and fibrosis after murine knee cartilage injury

Pirfenidone is an anti‐inflammatory and anti‐fibrotic drug that has shown efficacy in lung and kidney fibrosis. Because inflammation and fibrosis have been linked to the progression of osteoarthritis, we investigated the effects of oral Pirfenidone in a mouse model of cartilage injury, which results in chronic inflammation and joint‐wide fibrosis in mice that lack hyaluronan synthase 1 (Has1 −/− ) in comparison to wild‐type. Femoral cartilage...